Overview

A Clinical Trial of YH23537 in Patients With Knee Osteoarthritis

Status:
Completed
Trial end date:
2017-09-26
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate efficacy and safety of YH23537 versus celebrex in patients with knee osteoarthritis.
Phase:
Phase 2
Details
Lead Sponsor:
Yuhan Corporation
Treatments:
Celecoxib